PURPOSE: To explore the mix of physician specialties that long-term survivors visit and how the mix relates to preventive care. PATIENTS AND METHODS: Using the Surveillance, Epidemiology, and End Results-Medicare database, we conducted a retrospective, longitudinal study of stage I to III Medicare fee-for-service colorectal cancer patients diagnosed in 1997. We examined physician visits and preventive care each year for 5 years, starting 366 days postdiagnosis, and how preventive service receipt related to the physician mix seen: primary care provider (PCP) only, oncologist only, both, or neither. RESULTS: A total of 1,541 patients met the eligibility criteria (mean age, 76; 43% male; 85% white). During 5 years, PCP visits increased from a mean of 4.2 to 4.7 (P < .0001), and oncology visits decreased from 1.3 to 0.5 (P < .0001). Survivor care by PCPs only increased from 44% to 62%, whereas shared care by PCPs and oncologists dropped from 37% to 21% (P < .0001). Survivors who saw both PCPs and oncologists were most likely to receive influenza vaccination, mammograms, and cervical cancer screening; survivors who saw PCPs only were most likely to receive cholesterol screening and bone densitometry. Higher socioeconomic status was associated with increased influenza vaccination, mammograms, and cervical cancer screening (P < .05). Over time, there was a decrease in mammography and cervical cancer screening and an increase in influenza vaccination (P < .05). CONCLUSION: As oncologists become less involved in survivor care, cancer-related screening decreases significantly. These results support the need for survivorship care plans that explicitly outline the roles of PCPs and oncologists in sharing care for cancer survivors, and how these roles may change over time.
PURPOSE: To explore the mix of physician specialties that long-term survivors visit and how the mix relates to preventive care. PATIENTS AND METHODS: Using the Surveillance, Epidemiology, and End Results-Medicare database, we conducted a retrospective, longitudinal study of stage I to III Medicare fee-for-service colorectal cancerpatients diagnosed in 1997. We examined physician visits and preventive care each year for 5 years, starting 366 days postdiagnosis, and how preventive service receipt related to the physician mix seen: primary care provider (PCP) only, oncologist only, both, or neither. RESULTS: A total of 1,541 patients met the eligibility criteria (mean age, 76; 43% male; 85% white). During 5 years, PCP visits increased from a mean of 4.2 to 4.7 (P < .0001), and oncology visits decreased from 1.3 to 0.5 (P < .0001). Survivor care by PCPs only increased from 44% to 62%, whereas shared care by PCPs and oncologists dropped from 37% to 21% (P < .0001). Survivors who saw both PCPs and oncologists were most likely to receive influenza vaccination, mammograms, and cervical cancer screening; survivors who saw PCPs only were most likely to receive cholesterol screening and bone densitometry. Higher socioeconomic status was associated with increased influenza vaccination, mammograms, and cervical cancer screening (P < .05). Over time, there was a decrease in mammography and cervical cancer screening and an increase in influenza vaccination (P < .05). CONCLUSION: As oncologists become less involved in survivor care, cancer-related screening decreases significantly. These results support the need for survivorship care plans that explicitly outline the roles of PCPs and oncologists in sharing care for cancer survivors, and how these roles may change over time.
Authors: Kristin M Sheffield; Kristen T Crowell; Yu-Li Lin; Clarisse Djukom; James S Goodwin; Taylor S Riall Journal: Ann Surg Oncol Date: 2011-12-06 Impact factor: 5.344
Authors: Amresh D Hanchate; Kerri M Clough-Gorr; Arlene S Ash; Soe Soe Thwin; Rebecca A Silliman Journal: J Gen Intern Med Date: 2010-06-08 Impact factor: 5.128
Authors: Jessica R Schumacher; Whitney P Witt; Mari Palta; Noelle K Loconte; Susan M Heidrich; Amy Trentham-Dietz; Nancy Pandhi; Maureen A Smith Journal: J Am Board Fam Med Date: 2012 Jul-Aug Impact factor: 2.657
Authors: Hiroko Kunitake; Ping Zheng; Greg Yothers; Stephanie R Land; Louis Fehrenbacher; Jeffrey K Giguere; D Lawrence Wickerham; Lawrence Wickerham; Patricia A Ganz; Clifford Y Ko Journal: J Clin Oncol Date: 2010-11-15 Impact factor: 44.544
Authors: David A Haggstrom; Neeraj K Arora; Paul Helft; Marla L Clayman; Ingrid Oakley-Girvan Journal: J Gen Intern Med Date: 2009-11 Impact factor: 5.128
Authors: Winson Y Cheung; Noreen Aziz; Anne-Michelle Noone; Julia H Rowland; Arnold L Potosky; John Z Ayanian; Katherine S Virgo; Patricia A Ganz; Michael Stefanek; Craig C Earle Journal: J Cancer Surviv Date: 2013-03-24 Impact factor: 4.442